Norihiro Chatani

444 total citations
10 papers, 355 citations indexed

About

Norihiro Chatani is a scholar working on Molecular Biology, Hepatology and Epidemiology. According to data from OpenAlex, Norihiro Chatani has authored 10 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Hepatology and 5 papers in Epidemiology. Recurrent topics in Norihiro Chatani's work include Liver physiology and pathology (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Norihiro Chatani is often cited by papers focused on Liver physiology and pathology (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Norihiro Chatani collaborates with scholars based in Japan. Norihiro Chatani's co-authors include Tetsuo Takehara, Yuichi Yoshida, Yoshihiro Kamada, Shinichi Kiso, Takashi Kizu, Mina Hamano, Hisao Ezaki, Kunimaro Furuta, Norio Hayashi and Yoshikazu Nakaoka and has published in prestigious journals such as Hepatology, Biochemical and Biophysical Research Communications and American Journal of Physiology-Gastrointestinal and Liver Physiology.

In The Last Decade

Norihiro Chatani

10 papers receiving 352 citations

Peers

Norihiro Chatani
Marco Y. W. Zaki United Kingdom
Roman Liebe Germany
Abigale Lade United States
Anna Mae Diehl United States
Jennifer Demieville United States
Norihiro Chatani
Citations per year, relative to Norihiro Chatani Norihiro Chatani (= 1×) peers Mina Hamano

Countries citing papers authored by Norihiro Chatani

Since Specialization
Citations

This map shows the geographic impact of Norihiro Chatani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norihiro Chatani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norihiro Chatani more than expected).

Fields of papers citing papers by Norihiro Chatani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norihiro Chatani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norihiro Chatani. The network helps show where Norihiro Chatani may publish in the future.

Co-authorship network of co-authors of Norihiro Chatani

This figure shows the co-authorship network connecting the top 25 collaborators of Norihiro Chatani. A scholar is included among the top collaborators of Norihiro Chatani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norihiro Chatani. Norihiro Chatani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Yoshida, Yuichi, Takashi Kizu, Kunimaro Furuta, et al.. (2016). Increased expression of Forkhead box M1 transcription factor is associated with clinicopathological features and confers a poor prognosis in human hepatocellular carcinoma. Hepatology Research. 47(11). 1196–1205. 24 indexed citations
2.
Kizu, Takashi, Yuichi Yoshida, Kunimaro Furuta, et al.. (2015). Loss of Gab1 adaptor protein in hepatocytes aggravates experimental liver fibrosis in mice. American Journal of Physiology-Gastrointestinal and Liver Physiology. 308(7). G613–G624. 14 indexed citations
3.
Furuta, Kunimaro, Yuichi Yoshida, Takashi Kizu, et al.. (2015). Gab1 adaptor protein acts as a gatekeeper to balance hepatocyte death and proliferation during acetaminophen‐induced liver injury in mice. Hepatology. 63(4). 1340–1355. 26 indexed citations
4.
Furuta, Kunimaro, Yuichi Yoshida, Takashi Kizu, et al.. (2014). Parallel 7: Mechanisms of Hepatotoxicity. Hepatology. 60. 221A–224A. 3 indexed citations
5.
Chatani, Norihiro, Yoshihiro Kamada, Takashi Kizu, et al.. (2014). Secreted frizzled‐related protein 5 (Sfrp5) decreases hepatic stellate cell activation and liver fibrosis. Liver International. 35(8). 2017–2026. 33 indexed citations
6.
Yoshida, Yuichi, Shinichi Kiso, Takashi Kizu, et al.. (2013). Conditional loss of heparin-binding EGF-like growth factor results in enhanced liver fibrosis after bile duct ligation in mice. Biochemical and Biophysical Research Communications. 437(2). 185–191. 34 indexed citations
7.
Hamano, Mina, Hisao Ezaki, Shinichi Kiso, et al.. (2013). Lipid overloading during liver regeneration causes delayed hepatocyte DNA replication by increasing ER stress in mice with simple hepatic steatosis. Journal of Gastroenterology. 49(2). 305–316. 60 indexed citations
8.
Yoshida, Yuichi, Shinichi Kiso, Yukiko Saji, et al.. (2012). Conditional knockout of heparin‐binding epidermal growth factor‐like growth factor in the liver accelerates carbon tetrachloride‐induced liver injury in mice. Hepatology Research. 43(4). 384–393. 18 indexed citations
9.
Kamada, Yoshihiro, Shinichi Kiso, Yuichi Yoshida, et al.. (2012). Pitavastatin ameliorated the progression of steatohepatitis in ovariectomized mice fed a high fat and high cholesterol diet. Hepatology Research. 43(4). 401–412. 9 indexed citations
10.
Kamada, Yoshihiro, Shinichi Kiso, Yuichi Yoshida, et al.. (2011). Estrogen deficiency worsens steatohepatitis in mice fed high-fat and high-cholesterol diet. American Journal of Physiology-Gastrointestinal and Liver Physiology. 301(6). G1031–G1043. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026